Ks Medical Research Centre Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.71 M
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
About Ks Medical Research Centre
Ks Medical Research Centre Limited (KMRCL) is a Public Limited Indian Non-Government Company incorporated in India on 22 November 2005 and has a history of 19 years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.71 M, as per Ministry of Corporate Affairs (MCA) records.
Anil Jain, Arushi Jain, and Vandana Jain serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85110DL2005PLC142838
- Company No.
142838
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Ks Medical Research Centre?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Jain  | Director | 22-Nov-2005 | Current |
| Arushi Jain | Director | 22-Mar-2013 | Current |
| Vandana Jain | Director | 22-Nov-2005 | Current |
Financial Performance of Ks Medical Research Centre.
Ks Medical Research Centre Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ks Medical Research Centre?
In 2017, Ks Medical Research Centre had a promoter holding of 75.18% and a public holding of 24.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
All India Tennis Association.Anil Jain is a mutual person
Va Projects LimitedAnil Jain, Arushi Jain and 1 more are mutual person
- K.S.Research And Analysis Private Limited
Anil Jain, Arushi Jain and 1 more are mutual person
- Evera Auto India Private Limited
Arushi Jain and Vandana Jain are mutual person
- Avaa Active Wear Private Limited
Arushi Jain is a mutual person
- Dreamworld Projects Private Limited
Arushi Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ks Medical Research Centre?
Unlock and access historical data on people associated with Ks Medical Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ks Medical Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ks Medical Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
